Stanford faculty still taking drug firms' money
As medical schools wrestle with how to keep drug companies from corrupting their faculties, Stanford University is often lauded for its tough stance.
The school was one of the first to stop sales representatives from roaming its halls in 2006. It cut off the flow of free lunches and trinkets emblazoned with drug names. And last year, Stanford banned its physicians from giving paid promotional talks for pharmaceutical companies.
One thing it didn't do was make sure its faculty followed that rule.
- 5 Hot Healthcare Ideas from SXSW
- Hospital CEO Turnover Hits Record High
- Hospital Groups Strike Back at Hospital Rating Systems
- Another SGR Patch Likely, Lawmaker Says
- 4 Marketing Tactics for Hospitals on Instagram
- Rules to Rein in HIX Narrow Networks Could Drive Away Payers
- The Secret to Physician Engagement? It's Not Better Pay
- EHR Spending Continues, But Jury Still Out on ROI
- Care Coordination a Cost-Cutting Quality Driver
- Lahey Health Reexamines the Appropriate Care Model